FIREBRICK PHARMA
Who is FIREBRICK PHARMA?
Firebrick Pharma is an Australian pharmaceutical developer, which was founded in 2012 by Dr Peter Molloy and Dr Stephen Goodall with the mission to develop a nasal spray that killed all the germs (viruses or bacteria) responsible for respiratory infections, such as the common cold. After 9 years of ...See more
Industry & Specialities
Pharmaceuticals
Manufacturing
Countries of Operation
Australia Singapore
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2012 (14 years)
Address:
MELBOURNE, VICTORIA 3000, AU
Employees by Department
- The Rest (4)
- Total (4)
Key Decision Makers
Monique Baldwin
Peter Friedland
Chief Medical Officer
Peter Molloy
Founder, Executive Chairman
Tay Xin Pei J
Student Consultant
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
0employees
Non-managers
2employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has FIREBRICK PHARMA been operating for?
- What is the funding status of FIREBRICK PHARMA?
- Where is FIREBRICK PHARMA's headquarter?
- What FIREBRICK PHARMA's spending power?
- Does FIREBRICK PHARMA have a presence in the domain it operates in?